Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 2/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 2/20 | 1.00 |
| ▸ | DRD3 | P35462 | 2/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 1/20 | 1.00 |
| ▸ | CHRM3 | P20309 | 1/20 | 1.00 |
| ▸ | OPRD1 | P41143 | 1/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.72 |
| ▸ | LMNA | P02545 | 4/20 | 0.72 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.47 |
| ▸ | MITF | O75030 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Eperisone SCHEMBL1331682 | 1.00 | HRH3 (1.00) | HRH3CHRM2ADRA2BDRD3SIGMAR1 | |
| Eperisone SCHEMBL218337 | 0.99 | HRH3 (0.97) | HRH3CHRM2ADRA2BDRD3SIGMAR1 | |
| Inaperisone SCHEMBL250427 | 0.98 | HRH3 (0.97) | HRH3CHRM2ADRA2BDRD3SIGMAR1 | |
| Inaperisone SCHEMBL3990438 | 0.97 | CHRM2 (0.94) | HRH3CHRM2ADRA2BDRD3SIGMAR1 | |
| Inaperisone SCHEMBL1650087 | 0.96 | HRH3 (0.92) | HRH3CHRM2ADRA2BDRD3SIGMAR1 | |
| Eperisone SCHEMBL2491287 | 0.93 | HRH3 (0.87) | HRH3CHRM2ADRA2BDRD3SIGMAR1 | |
| Eperisone SCHEMBL1329969 | 0.93 | HRH3 (0.87) | HRH3CHRM2ADRA2BDRD3SIGMAR1 | |
| Eperisone SCHEMBL1331476 | 0.92 | HRH3 (0.85) | HRH3CHRM2ADRA2BDRD3SIGMAR1 | |
| Eperisone SCHEMBL2489151 | 0.92 | HRH3 (0.85) | HRH3CHRM2ADRA2BDRD3SIGMAR1 | |
| Eperisone SCHEMBL1331479 | 0.92 | HRH3 (0.85) | HRH3CHRM2ADRA2BDRD3SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1535 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| CN-119792221-A | Pharmaceutical composition and preparation method and application thereof | 江苏吴中医药集团有限公司 | 2025-04-11 | — | — | CN | claimed |
| WO-2025062440-A1 | TOPICAL NANO-DISPERSION COMPOSITIONS AND THEIR PREPARATION THEREOF | PULSE PHARMACEUTICALS PVT. LTD (IN) | 2025-03-27 | — | — | WO | claimed |
| CN-119330913-A | Preparation method of eperisone hydrochloride | 康普药业股份有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-118593492-A | Application of eperisone in treating pulmonary fibrosis caused by silicon dust | 山西医科大学 | 2024-09-06 | — | — | CN | claimed |
| CN-118436591-A | External preparation of betahistine and application thereof | 山东序列生物科技有限公司 | 2024-08-06 | — | — | CN | claimed |
| CN-118436593-A | External preparation of eperisone and application thereof | 山东序列生物科技有限公司 | 2024-08-06 | — | — | CN | claimed |
| CN-118436592-A | Dantrolin sodium external preparation and preparation method and application thereof | 山东序列生物科技有限公司 | 2024-08-06 | — | — | CN | claimed |
| CN-117209455-B | Refining and purifying method of eperisone hydrochloride | 北京沃邦医药科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117209455-A | Refining and purifying method of eperisone hydrochloride | 北京沃邦医药科技有限公司 | 2023-12-12 | — | — | CN | claimed |
| US-5073375-A | Monoglyceride or lactic acid ester | SANSHO CO., LTD. (JP) | 1991-12-17 | — | — | US | claimed |
| CN-1056055-A | Eperisone and mydocalm preparation that percutaneous absorbs | SEIKISUI CHEMICAL CO LTD (JP) | 1991-11-13 | — | — | CN | claimed |
| EP-0454089-A1 | Percutaneously absorbable eperisone or tolperisone preparation | SEKISUI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1991-10-30 | — | — | EP | claimed |
| US-5059427-A | PHARMACEUTICAL PREPARATION FOR PERCUTANEOUS ADMINISTRATION CONTAINING EPERISONE OR TOLPERISONE OR SALT THEREOF | SANSHO CO., LTD. (JP) | 1991-10-22 | — | — | US | claimed |
| US-5002958-A | P-Ethyl-2-Methyl-3-Piperidinopropiophenone | EISAI CO., LTD. (JP) | 1991-03-26 | — | — | US | claimed |
| EP-0295411-B1 | PHARMACEUTICAL PREPARATION FOR PERCUTANEOUS ADMINISTRATION CONTAINING EPERISONE OR TOLPERISONE OR A SALT THEREOF | Sansho Co., Ltd. (JP) | 1990-09-05 | — | — | EP | claimed |
| US-4912116-A | Propiophenone derivatives for treatment of pollakiuria (frequency urination) | HOKURIKU PHARMACEUTICAL CO., LTD. (JP) | 1990-03-27 | — | — | US | claimed |
| EP-0295411-A1 | Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or a salt thereof | Sansho Co., Ltd. (JP) | 1988-12-21 | — | — | EP | claimed |
| US-4181803-A | 4'-SUBSTITUTED-2-METHYL-3-PIPERIDINO-PROPIOPHENONES; ANTISPASMODIC AGENTS, MUSCLE RELAXANTS | EISAI CO., LTD. (JP) | 1980-01-01 | — | — | US | claimed |
| US-3995047-A | Propiophenone derivatives in the treatment of pathological muscular conditions | EISAI CO., LTD. (JA) | 1976-11-30 | — | — | US | claimed |